Analysis of gene expression in the GCs that produced the previously described CCM—characterized for its hormone and IL-6 contents showed distinct inflammatory, proliferative, and steroidogenic expression patterns (Figure 7). The gene discussed is IL6; the disease is cerebral cavernous malformation.